From: Concurrent chemoradiotherapy in adjuvant treatment of breast cancer
Factor | P value |
---|---|
Age: <40 vs ≥ 40 | 0.221 |
SBR: I vs SBR II-III | 0.402 |
HR: positive vs negative | 0.675 |
Tumour: pT1–2 vs pT3–4 | 0.263 |
Lymph node involvement: yes vs no | 0.007 |
Regimen: CMF vs Anthracycline | 0.428 |